
Joel Wright, chief executive officer, AllianceRx Walgreens Prime discusses how specialty pharmacies can leverage retail pharmacies connections to negotiate costs.

Joel Wright, chief executive officer, AllianceRx Walgreens Prime discusses how specialty pharmacies can leverage retail pharmacies connections to negotiate costs.

Moses Zonana, CEO of Compliance Meds Technologies, discusses the impact of medication nonadherence.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how Walgreens has encouraged their pharmacists to continue their education.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what considerations must be made to create a care management program in the specialty space.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses how to improve patient outcomes and decrease oncology spend.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses why streamlining specialty pharmacy care is important.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of disruption.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, takes a legal perspective on direct and indirect remuneration fees and how they affect specialty pharmacies.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime speaks to how medication synchronization programs can improve adherence.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses promising specialty drugs to watch out for in the pipeline.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.


David DeRemer, PharmD, Assistant Director of Clinical Therapeutics and Incubator, Clinical Associate Professor at the University of Florida College of Pharmacy, discusses resources to help educate patients on oral chemotherapy agents.

As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign.

In this clip, Randy Burkholder, Vice President of Policy and Research at PhRMA, discusses the health care policy changes that are needed to help alleviate the financial hardships faced by cancer patients.

Pharmacists have an important role in the care of oncology patients, especially in managing their treatments and providing support to physicians.

At the National Community Oncology Dispensing Association (NCODA) Fall Summit, Mario Lacouture, MD, discussed the importance of managing quality of life conditions, such as skin, hair, and nail conditions, in patients undergoing cancer treatments.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what role pharmacists have in combating the opioid epidemic.



Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the struggle with high-cost specialty medications and the alternatives for providing specialty pharmacy care.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, speaks to the merits of partnering with continuing education and advocacy organizations.

PQIs, developed by a team of NCODA clinical pharmacists, provide medication management tools that focus on specific issues associated with managing oral cancer drug therapies.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the potential impact biosimilars will have in health care.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, talks about using medical marijuana for the treatment of specialty conditions.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the impact of orphan drugs across the specialty landscape.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the negative impact of a slow turnaround on patient care.